C16G2
C3J14-201B-00
Phase 2 small_molecule completed
Quick answer
C16G2 for Dental Caries is a Phase 2 program (small_molecule) at Armata Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Armata Pharmaceuticals
- Indication
- Dental Caries
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed